<!DOCTYPE html>
<!-- paulirish.com/2008/conditional-stylesheets-vs-css-hacks-answer-neither/
-->
<!--[if lt IE 7]>
<html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en">
<![endif]-->
<!--[if IE 7]>
<html class="no-js lt-ie9 lt-ie8" lang="en">
<![endif]-->
<!--[if IE 8]>
<html class="no-js lt-ie9" lang="en">
<![endif]-->
<!--[if gt IE 8]>
<!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<head>
    <meta charset="utf-8" />
    <!-- Set the viewport width to device width for mobile -->
    <meta name="viewport" content="width=device-width" />
    <title>
        PracticeUpdate : Expert Opinion Item
    </title>
    <link rel="stylesheet" href="assets/css/app.css">
    <link rel="stylesheet" href="assets/css/font-awesome.css">
    <link rel="stylesheet" href="assets/css/fc-webicons.css">
    <link rel="stylesheet" href="assets/css/foundation-icons-general.css">
    <script src="assets/js/foundation/modernizr.foundation.js">
    </script>
    <!-- IE Fix for HTML5 Tags -->
    <!--[if lt IE 9]>
        <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js">
        </script>
    <![endif]-->
</head>

<body id="page" class="update off-canvas slide-nav expert-opinion-item logged-out">
    <div class="widget ad">
        <div id="leaderboard" class="Breast ad-container">
            <div class="ad-title">
                <span class="ad-title-text">
                    advertisement
                </span>
            </div>
            <!--/.ad-title-->
            <div id="leaderboardcontent" class="ad-content">
            </div>
            <!--.ad-content-->
        </div>
        <!--/#leaderboard.ad-container-->
    </div>
    <!--/.widget.ad-->
    <div class="page-header">
    </div>
    <!--/.page-header-->
    <div class="page-content">
        <section role="main">
            <div class="single-item-container">
                <article class="type-expert-opinion single-item">
                    <!-- info taken from: http://oncologystat.com/viewpoints/seminal_articles/Seminal_Articles_Germ_Cell_Tumors.html
                    -->
                    <div class="item-header-container">
                        <header class="item-header">
                            <div class="flag-container">
                                <span class="flag featured">
                                    <i class="icon-bolt">
                                    </i>
                                    featured
                                </span>
                                <span class="flag story-of-the-week">
                                    <i class="icon-bolt">
                                    </i>
                                    story of the week
                                </span>
                            </div>
                            <div class="meta pub-meta">
                                <span class="item-type">
                                    Seminal Article
                                </span>
                                <span class="item-pub-date">
                                    <time datetime="12-12-19">
                                        December 19, 2012
                                </span>
                            </div>
                            <hgroup class="item-title-container">
                                <h1 class="item-title">
                                    Seminal Articles—Esophageal and Gastroesophageal Junction Cancer
                                </h1>
                                <p class="item-citation">
                                    <!-- {{source.citation}} -->
                                    2012 Jun 1, David Ilson, MD, Editor: Matthew Eadens, MD
                                </p>
                            </hgroup>
                            <!-- /.item-title-container -->
                        </header>
                    </div>
                    <!--/.item-header-container-->
                    <div class="item-content-container">
                        <div class="item-content">
                            <div class="item-content-section">
                                <section class="seminal-article-body">
                                    <div class="seminal-article-body-container">
                                        <div class="source-container">
                                            <div class="vcard">
                                            </div>
                                            <!--/.vcard-->
                                        </div>
                                        <!--/.source-container-->
                                        <p>Based on our expert’s review, here are the must-read articles for every oncologist about esophageal and gastroesophageal junction cancer.</p><p><strong>Epidemiology</strong></p><p>1. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0142%2819981115%2983:10%3C2049::AID-CNCR1%3E3.0.CO;2-2/full">Cancer. 1998; 83:2049-2053</a>.</p><p>2. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. <a target="_blank" href="http://jama.ama-assn.org/content/285/18/2331.long">JAMA. 2001; 285(18): 2331-2338</a>. <strong>Free</strong></p><p>3. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. <a target="_blank" href="http://jnci.oxfordjournals.org/content/96/5/388.full">J Natl Cancer Inst. 2004; 96:388-396</a>. <strong>Free</strong></p><p><strong>Barrett’s Esophagus</strong></p><p>4. Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. <a target="_blank" href="http://jama.ama-assn.org/content/287/15/1972.full">JAMA. 2002; 287:1972-1981</a>. <strong>Free</strong></p><p>5. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa1103042">N Engl J Med. 2011; 365:1375-1383</a>.</p><p>6. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa0808145">N Engl J Med. 2009; 28: 2277-2288</a>. <strong>Free</strong></p><p><strong>Staging</strong></p><p>7. Siewert JR, Feith M, M. Werner, M. Adenocarcinoma of the Esophagogastric Junction; Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1,002 Consecutive Patients. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421149/">Ann Surg. 2000 September; 232(3): 353&ndash;361</a>. <strong>Free</strong></p><p>8. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a meta-analysis. <a target="_blank" href="http://www.nature.com/bjc/journal/v98/n3/full/6604200a.html">Br J Cancer. 2008; 98:547-557</a>. <strong>Free</strong></p><p>9. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. <a target="_blank" href="http://jco.ascopubs.org/content/18/18/3202.full">J Clin Oncol. 2000; 18:3202-3210</a>.</p><p><strong>Surgery</strong></p><p>10. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa022343">N Engl J Med. 2002; 347(21): 1662-1669</a>. <strong>Free</strong></p><p>11. Chang AC, Ji H, Birkmeyer NJ, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0003497507020395">Ann Thorac Surg. 2008; 85(2): 424-429</a>.</p><p>12. Wolff CS, Castillo SF, Larson DR, et al. Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy. <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2050.2007.00785.x/full">Dis Esophagus. 2008; 21:328-333</a>.</p><p>13. Groth SS, Whitson BA, Li Z, et al. Determination of the ideal number of lymph nodes to examine to optimize survival in patients with esophageal carcinoma: Data from the surveillance epidemiology and end results database. <a target="_blank" href="http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/4528">J Clin Oncol (Meeting Abstracts). 2008; 26: 4528</a>.</p><p>14. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. <a target="_blank" href="http://journals.lww.com/annalsofsurgery/Abstract/2010/01000/Optimum_Lymphadenectomy_for_Esophageal_Cancer.7.aspx">Ann Surg. 2010; 251(1): 46-50</a>.</p><p><strong>Locoregional Disease Treatment</strong></p><p>15. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJM199206113262403">N Engl J Med. 1992; 326:1593-1598</a>. <strong>Free</strong></p><p>16. Allum WH, Stenning SP, Bancewicz J. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. <a target="_blank" href="http://jco.ascopubs.org/content/27/30/5062.long">J Clin Oncol. 2009 Oct 20;27(30):5062-7</a>.</p><p>17. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. <a target="_blank" href="http://jama.ama-assn.org/content/281/17/1623.full.pdf">JAMA. 1999; 281:1623-1627</a>. <strong>Free</strong></p><p>18. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. <a target="_blank" href="http://jco.ascopubs.org/content/23/10/2310.full">J Clin Oncol. 2005; 23:2310-2317</a>.</p><p>19. Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamour cancer of the esophagus: FFCD 9102. <a target="_blank" href="http://jco.ascopubs.org/content/25/10/1160.long">J Clin Oncol. 2007; 25(10): 1160-1168</a>.</p><p>20. Kelsen DP, Winter KA, Gunderson LL, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. <a target="_blank" href="http://jco.ascopubs.org/content/25/24/3719.long">J Clin Oncol. 2007; 25(24): 3719-3725</a>.</p><p>21. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa055531">N Engl J Med. 2006; 355:11-20</a>. <strong>Free</strong></p><p>22. Sjoquist KM, Burmeister BH, Smithers BM. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. <a target="_blank" href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2811%2970142-5/fulltext">Lancet Oncol. 2011 Jul;12(7):681-92</a>.</p><p>23. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. <a target="_blank" href="http://jco.ascopubs.org/content/26/7/1086.full">J Clin Oncol. 2008; 26:1086-1092</a>.</p><p>24. van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa1112088">N Engl J Med 2012; 366:2074-2084 May 31, 2012</a>.</p><p>25. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. <a target="_blank" href="http://jco.ascopubs.org/content/27/6/851.long">J Clin Oncol. 2009; 27(6): 851-856</a>.</p><p>26. Ychou M, Boige V, Pignon JP. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. <a target="_blank" href="http://jco.ascopubs.org/content/29/13/1715.abstract?sid=d3056a56-f985-4572-8c6d-5991e260bc00">J Clin Oncol. 2011;29(13):1715</a>.</p><p><strong>Unresectable/Metastatic Disease Treatment</strong></p><p>26. Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. <a target="_blank" href="http://jco.ascopubs.org/content/24/18/2903.long">J Clin Oncol. 2006; 24(18): 2903-2909</a>.</p><p>27. Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. <a target="_blank" href="http://jco.ascopubs.org/content/15/1/261.long">J Clin Oncol. 1997; 15(1): 261-267</a>.</p><p>28. Ross P, Nicolson M, Cunningham D, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. <a target="_blank" href="http://jco.ascopubs.org/content/20/8/1996.long">J Clin Oncol. 2002; 1996-2004</a>.</p><p>29. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. <a target="_blank" href="http://jco.ascopubs.org/content/24/31/4991.long">J Clin Oncol. 2006; 24(31): 4991-4997</a>.</p><p>30. Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa073149">N Engl J Med. 2008; 358(1): 36-46</a>. <strong>Free</strong></p><p>31. Dank M, Zaluski J, Barone C, et al. Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naïve patients with advaced adenocarcinoma of the stomach or esophagogastric junction. <a target="_blank" href="http://annonc.oxfordjournals.org/content/19/8/1450.long">Ann Oncol. 2008; 19(8): 1450-1457</a>. FREE</p><p>32. Al-Batran SE, Hartmann JT, Probst S, et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. <a target="_blank" href="http://jco.ascopubs.org/content/26/9/1435.long">J Clin Oncol. 2008; 26(9): 1435-1442</a>.</p><p>33. Enzinger PC, Burtness B, Hollis D, et al. CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE juncion cancer. <a target="_blank" href="http://www.asco.org/ascov2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=74&amp;abstractID=44487">J Clin Oncol (Meeting Abstracts). 2010; 28: 4006</a>.</p><p>34. Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S014067361061121X">Lancet. 2010; 376(9742): 687-697</a>.</p><p>35. Kang YK, Kang WK, Shin DB. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. <a target="_blank" href="http://annonc.oxfordjournals.org/content/20/4/666.long">Ann Oncol. 2009 Apr;20(4):666-73</a>. <strong>Free</strong></p><p></p>
                                    </div>
                                    <!--/.seminal-article-body-container -->
                                </section>
                                <!-- /.seminal-article-body -->
                            </div>
                            <!-- ./item-content-section -->
                        </div>
                        <!-- ./item-content -->
                    </div>
                    <!-- /.item-conten-container -->
                    <hr />
                    <footer class="copyright item-footer">
                        <img class="logo" src="content/img/feed/imng_logo.gif" alt="IMNG Medical Media"
                        />
                        <p>
                            Copyright &copy; 2012 Elsevier
                        </p>
                    </footer>
            </div>
            <!--/.item-container-->
            <div class="recommended">
                <div class="recent">
                </div>
                <!--/.recent-->
                <div class="ad">
                    <img src="http://placehold.it/300x250" align="ad" title="ad" />
                </div>
            </div>
            <!--/.recommended-->
        </section>
        <!--/[role="main"]-->
        <section id="sidebar" role="complementary">
            <div class="dashboard">
                <div class="panel cta register">
                    <p>
                        <!-- Meet Our Experts -->
                        Become a member to customize this page.
                        <p>
                            <a class="button" href="#action-register">Register for free</a>
                </div>
                <!--/.panel.cta.register-->
                <div class="component user-console">
                </div>
                <!--/.component.user-console-->
                <div class="component user-topic">
                </div>
                <!--/.component.user-topic-->
                <div class="component topic-spotlight">
                </div>
                <!--/.component.topic-spotlight-->
                <div class="panel">
                    <img src="http://placehold.it/200x200" />
                    <p>
                        <!-- Meet Our Experts -->
                        Meet our Advisory and Editorial Boards comprised of physician editors
                        and world-renowned experts.
                        <p>
                </div>
            </div>
            <!--/.sidebar-->
        </section>
        <!--/.[role="complimentary"]-->
    </div>
    <!--/.page-content-->
    <footer class="page-footer">
    </footer>
    <!-- /.page-footer -->
    <!-- Included JS Files (Uncompressed) -->
    <script src="assets/js/foundation/jquery.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.accordion.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.alerts.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.buttons.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.forms.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.mediaQueryToggle.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.navigation.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.orbit.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.reveal.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tabs.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tooltips.js">
    </script>
    <script src="assets/js/foundation/jquery.placeholder.js">
    </script>
    <script src="assets/js/foundation/app.js">
    </script>
    <script src="assets/js/foundation/jquery.offcanvas.js">
    </script>
    <script src="assets/js/mustache.js">
    </script>
    <!-- Mustache - homepage feed template -->
    <script>
                    	<!--
	Mustache - homepage feed template -->
	$.getJSON('content/json/feed.json', function(data) {
	    $.get('assets/mustache/feed-item.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.stream-container').html(html);
	    });

	});

	<!--
	Mustache - homepage recent template -->
	$.getJSON('content/json/recent.json', function(data) {
	    $.get('assets/mustache/recent.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.recent').html(html);
	    });

	});

	<!--
	Mustache - homepage user - console template -->
	$.getJSON('content/json/user-console.json', function(data) {
	    $.get('assets/mustache/user-console.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-console').html(html);
	    });
	});

	<!--
	Mustache - homepage user - topic template -->
	$.getJSON('content/json/user-topic.json', function(data) {
	    $.get('assets/mustache/user-topic.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-topic').html(html);
	    });
	});

	<!--
	Mustache - homepage topic - spotlight template -->
	$.getJSON('content/json/topic-spotlight.json', function(data) {
	    $.get('assets/mustache/topic-spotlight.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.topic-spotlight').html(html);
	    });
	});
</script>
</body>

</html>